Viewing Study NCT05134532


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2026-04-08 @ 3:03 PM
Study NCT ID: NCT05134532
Status: UNKNOWN
Last Update Posted: 2023-04-26
First Post: 2021-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC
Sponsor: CHA University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular carcinoma View
None Liver Cancer View